JF Healthcare: proposes to repurchase shares not exceeding HK$350 million.

Jingfang Pharma announced that it plans to repurchase H shares on the open market from time to time, with a maximum amount not exceeding HK$350 million, and the repurchase period will expire upon the expiration of the authorization period for repurchasing shares.